Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease

BACKGROUND: Despite substantial research and development investment in Alzheimer’s disease (AD), effective therapeutics remain elusive. Significant emerging evidence has linked cholesterol, β-amyloid and AD, and several studies have shown a reduced risk for AD and dementia in populations treated wit...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Alzheimers Res Ther
Главные авторы: Geifman, Nophar, Brinton, Roberta Diaz, Kennedy, Richard E., Schneider, Lon S., Butte, Atul J.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2017
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5316146/
https://ncbi.nlm.nih.gov/pubmed/28212683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0237-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы